Interactive Signaling Modules in Vascular Inflammation
Interactive Signaling Modules in Vascular Inflammation
批准号:
7921379
负责人:
LINDA H SHAPIRO
金额:
$161.96万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-07-01 至 2014-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The competitive renewal of the program project application "Interactive signaling modules in vascular inflammation" is focused on the process of inflammatory changes in the vessel wall that lead to atherosclerosis. The program brings together seven independent investigators interested in the vascular biology. The theme of the program is to define molecular mechanisms important for pathologic inflammatory events with a focus on myeloid cells. The central hypothesis is that interactions between distinct signal transduction modules influence fundamental cellular processes such as cell-cell interaction, cell migration, inflammation, death and engulfment of apoptotic cells, ultimately altering the pathogenesis and progression of atherosclerosis. Each project in the program focuses on a unique aspect of the theme to advance our understanding of inflammatory vascular phenotypes. Project 1 (Hla) proposes to investigate the role of sphingosine 1-phosphate on macrophage inflammasome function and atherogenesis. This project shares several common interests with Project 2 (Wu), which is focused on PLCB regulation of macrophage apoptosis and atherogenesis. Project 3 (Han) focuses on the process of cell-cell recognition process by which apoptotic cells are cleared from the vascular wall. Thus, this project has common interests as projects 2 and 4. Project 4 (Shapiro) focuses on the novel role of the cell-surface molecule CD13 in the adhesion of myeloid cells to vascular endothelial cells, and explores this mechanism in vascular pathology. All the projects utilize molecular, biochemical, cell biological and in vivo mouse models. Thus three cores, administrative, fluorescence imaging and vascular histology and atherosclerosis are proposed to support the projects with state-of-the-art technology. All the projects and cores interact and mutually reinforce each other to achieve the goals of the program in a synergistic manner. Coupled with strong institutional support to the Center for Vascular Biology, it is anticipated that significant new insights on vascular inflammation and atherosclerosis will be forthcoming from this renewal program project application. RELEVANCE (See instructions): Inflammation in the vessel wall is important in atherosclerosis, which leads to heart attacks. Blood monocytes enter the vessel wall, differentiate into macrophages and sustain inflammation. This project will focus on new mechanisms of monocyte entry, macrophage inflammatory mechanisms, macrophage survival and engulfment of dead or apoptotic cells. These collaborative studies should lead to better understanding of atherosclerosis and provide potential new therapeutic directions to control atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endocytic Regulation of Inflammation
-
批准号:9312915
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2015
-
负责人:LINDA H SHAPIRO
-
依托单位:
Endocytic Regulation of Inflammation
-
批准号:8972844
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2015
-
负责人:LINDA H SHAPIRO
-
依托单位:
Endocytic Regulation of Inflammation
-
批准号:9509485
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2015
-
负责人:LINDA H SHAPIRO
-
依托单位:
Role of CD13 and its activators in vascular inflammation
-
批准号:8150053
-
项目类别:
-
资助金额:$38.73万
-
财政年份:2010
-
负责人:LINDA H SHAPIRO
-
依托单位:
The Role of CD13 and its activators in vascular inflammation
-
批准号:7662916
-
项目类别:
-
资助金额:$39.42万
-
财政年份:2009
-
负责人:LINDA H SHAPIRO
-
依托单位:
Adminstrative Core
-
批准号:7662917
-
项目类别:
-
资助金额:$11.46万
-
财政年份:2009
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD13 as a Biomaker for Chemoprevention of Breast ca,
-
批准号:7069507
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2005
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD13 as a Biomaker for Chemoprevention of Breast Cancer
-
批准号:7620059
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2005
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD13 as a Biomarker for Chemoprevention of Breast Cancer
-
批准号:6875826
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2005
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD13 as a Biomarker for NSAIDS Chemoprevention of Breast Cancer
-
批准号:7416712
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2005
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD13 as a Biomarker for NSAIDS Chemoprevention of Breast Cancer
-
批准号:7249485
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2005
-
负责人:LINDA H SHAPIRO
-
依托单位:
Interactive Signaling Modules in Vascular Inflammation
-
批准号:8266925
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2002
-
负责人:LINDA H SHAPIRO
-
依托单位:
Interactive Signaling Modules in Vascular Inflammation
-
批准号:8467009
-
项目类别:
-
资助金额:$161.31万
-
财政年份:2002
-
负责人:LINDA H SHAPIRO
-
依托单位:
Interactive Signaling Modules in Vascular Inflammation
-
批准号:7632405
-
项目类别:
-
资助金额:$163.1万
-
财政年份:2002
-
负责人:LINDA H SHAPIRO
-
依托单位:
Interactive Signaling Modules in Vascular Inflammation
-
批准号:8307874
-
项目类别:
-
资助金额:$169.98万
-
财政年份:2002
-
负责人:LINDA H SHAPIRO
-
依托单位:
Interactive Signaling Modules in Vascular Inflammation
-
批准号:8098053
-
项目类别:
-
资助金额:$161.89万
-
财政年份:2002
-
负责人:LINDA H SHAPIRO
-
依托单位:
Maf Molecular Interactions in Hematopoiesis
-
批准号:6496632
-
项目类别:
-
资助金额:$9.76万
-
财政年份:2001
-
负责人:LINDA H SHAPIRO
-
依托单位:
CD154-CD13 Pathway in Inflammation-driven Angiogenesis
-
批准号:6778296
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2001
-
负责人:LINDA H SHAPIRO
-
依托单位:
Maf Molecular Interactions in Hematopoiesis
-
批准号:6640686
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2001
-
负责人:LINDA H SHAPIRO
-
依托单位:
Maf Molecular Interactions in Hematopoiesis
-
批准号:6732773
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2001
-
负责人:LINDA H SHAPIRO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
USP51/Zeb1 signaling调控乳腺癌化疗耐药的病理机制及其靶向干预研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:杨爽
-
依托单位:
Zeb1/IL-8 signaling调控乳腺癌免疫微环境重塑的机制研究
-
批准号:81972454
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:杨爽
-
依托单位:
Ptch1 基因通过 Hh 信号通路(Hedgehog signaling pathway)对卵巢癌细胞增殖和凋亡的影响
-
批准号:
-
项目类别:省市级项目
-
资助金额:3.0万元
-
批准年份:2019
-
负责人:
-
依托单位:--
HBx-FXR signaling相关LncRNA在原发性肝癌中的作用及机制研究
-
批准号:81772972
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2017
-
负责人:牛永东
-
依托单位:
IL-6 trans-signaling调控腹膜血管新生和通透性增高的机制研究
-
批准号:81670691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:方炜
-
依托单位:
DDR signaling诱导Apoptin促肿瘤放射增敏治疗的研究
-
批准号:81272488
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:韩苏夏
-
依托单位: